Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease

NCT06499233 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Pneumonia, Pneumocystis
Autoimmune Inflammatory Rheumatic Disease
Autoimmune Diseases
Connective Tissue Disease
Prevention

Interventions

DRUG: Trimethoprim/Sulfamethoxazole

Sponsor

Tongji Hospital